Business
Statement re CVA
Statement re CVA.
About this update from Iconic Labs Plc
[{"type":"text","content":"\n\n \n \n 12 September 2023\nIconic Labs PLC\n \n(\"Iconic\" or the \"Company\")\n \nAllotment of Shares and Conclusion of CVA\n \nIconic Labs PLC (LSE: ICON) today announces that 83,256 ordinary shares of £0.1 were allotted to the unsecured creditors (the \"Unsecured Creditors\") in accordance with the Creditors Voluntary Arrangement (CVA) dated 22 September 2022.\n \nApplication is being made for 83,256 new Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange which is expected to be on or around 15 September 2023. These shares rank pari passu with the existing Ordinary Shares of the Company.\n \nFollowing the issue of these shares, the Company's issued ordinary share capital shall consist of 5,003,275 Ordinary Shares. The figure of 5,003,275 represents the total voting rights in the Company and should be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance & Transparency Rules.\n \nBrad Taylor, Chief Executive Officer of Iconic Labs, commented:\n \n\"We are pleased to announce the allotment of shares to the Unsecured Creditors satisfies the final condition to bring the CVA to a successful conclusion. Once the CVA is discharged, Iconic will be well positioned to focus on its business goals. The Board remains committed to delivering value to our shareholders and stakeholders alike.\"\n \n- Ends -\n \nThis announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (\"MAR\"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.\n \nFor any further information or enquiries please contact:\n \n\n\n\nIconic Labs\nBrad Taylor, Chief Executive Officer\n\n\nTel: +44 (0) 7462 156238\[email protected]\n\n\n\n\nNovum Securities Limited\nDavid Coffman / Daniel Harris\n\n\nTel: +44 (0) 20 7399 9400\n \n\n\n\n\nYellow Jersey PR\nSarah Hollins\nAnnabelle Wills\nBessie Elliot\n \n\n\nTel: +44 (0) 20 3004 9512\niconic@yellowjerseypr....